Neural Compensation, Visual Function and Visual Quality After Monofocal or Multifocal Intraocular Lens Implantation

Sponsor
Sun Yat-sen University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02644720
Collaborator
First Affiliated Hospital, Sun Yat-Sen University (Other)
50
1
2
60
0.8

Study Details

Study Description

Brief Summary

Multifocal intraocular lenses (MIOLs) provide enhanced far and near visual acuity, but they can bring about halos and glare, which are caused by design deficiencies of the IOLs. Compared to monofocal intraocular lens, pseudo accommodation in nonphysiological state may increase the difficulty of neural compensation reconstruction in patients with multifocal intraocular lens implantation. Patients enrolled into the study will be followed for 1 year and will have study visits preoperatively, at 1 week, 3 months, 6 months, 12 months postoperatively.In this trial, we aimed to specify the time of neural compensation reconstruction in patients and to explore the changes of visual function in senile patients with monofocal or multifocal intraocular lens implantation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: multifocal intraocular lens implantation
  • Procedure: monofocal intraocular lens implantation
  • Drug: Dexamethasone
  • Device: multifocal intraocular lens (IOL) (Tecnis ZMB00)
  • Device: monofocal intraocular lens (IOL) (Tecnis ZCB)
N/A

Detailed Description

Cataract extraction and intraocular lens (IOL) implantation are the current standard treatments for age-related cataract (ARC). Cataract surgery increases visual acuity but may lead to complaints after surgery. Multifocal intraocular lenses (MIOLs) provide enhanced far and near visual acuity, but they can bring about halos and glare, which are caused by design deficiencies of the IOLs. Fortunately, most of the halos and glare diminish with time. Niels et al noted that neural adaptation (NA) may explain the lower incidence of glare and halos in their study. Compared to monofocal intraocular lens, pseudo accommodation in nonphysiological state may increase the difficulty of neural compensation reconstruction in patients with multifocal intraocular lens implantation.

In the present study, the investigators evaluated the activity of neurons in the visual cortex using fMRI both preoperatively and postoperatively. In addition, the investigators evaluated postoperative changes in VF, including visual acuity (VA), contrast sensitivity (CS), straylight values (SVs), and pattern visual evoked potential (PVEP), stereoscopic vision, wavefront aberrations at 1 week, 3 months, 6 months, 12 months postoperatively.In this trial, the investigators aimed to specify the time of neural compensation reconstruction in patients and to explore the changes of visual function in senile patients with monofocal or multifocal intraocular lens implantation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Neural Compensation, Visual Function and Visual Quality in Senile Cataract Patients After Monofocal or Multifocal Intraocular Lens Implantation
Study Start Date :
Jan 1, 2014
Anticipated Primary Completion Date :
Jan 1, 2019
Study Completion Date :
Jan 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: multifocal intraocular lens group

Procedure: multifocal intraocular lens implantation
In this group, the surgery was performed with cataract extraction and multifocal intraocular lens (IOL) (Tecnis ZMB00). The standard technique in all patients consisted of sutureless phacomulsifacation using the Legacy 2000 Series and Infinity phacoemulsification machine (Alcon Laboratories Inc., Fort Worth, Texas, USA), with clear corneal incisions up to 3.2 mm and 5.0 to 5.5 mm capsulorhexis. Surgery in the fellow eye was performed 1 month later in each patient.

Drug: Dexamethasone
All patients received subconjunctival dexamethasone (2 mg) during surgery

Device: multifocal intraocular lens (IOL) (Tecnis ZMB00)

Active Comparator: monofocal intraocular lens group

Procedure: monofocal intraocular lens implantation
In the group, the surgery was performed with cataract extraction and monofocal intraocular lens (IOL) (Tecnis ZCB). The surgery technique was same as the multifocal intraocular lens group

Drug: Dexamethasone
All patients received subconjunctival dexamethasone (2 mg) during surgery

Device: monofocal intraocular lens (IOL) (Tecnis ZCB)

Outcome Measures

Primary Outcome Measures

  1. Change from contrast sensitivity [1 week, 1 month, 3 month, 6 month,1 year after surgery]

    Contrast sensitivity (CS) was tested with a Contrast Glare Tester 1000

  2. Change from functional magnetic resonance imaging [1 week, 1 month, 3 month, 6 month,1 year after surgery]

Secondary Outcome Measures

  1. Change from best corrected visual acuity [1 week, 1 month, 3 month, 6 month,1 year after surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • visual acuity less than 0.3

  • Cataracts in both eyes classified by the Lens Opacity Classification System III

  • Corneal astigmatism less than 1.5 diopters (D)

  • Capability of understanding and signing the informed consent

Exclusion Criteria:
  • Corneal astigmatism ≥ 1.5D.

  • History of neurological or psychiatric disorders; systemic disease such as severe hypertension or diabetes mellitus that might interfere with the visual outcomes.

  • Associated ocular disease that could interfere with final results

  • Previous anterior and posterior segment surgery and intraoperative or postoperative complications

  • Driving at night frequently; excessive expectations for visual outcomes

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhognshan Ophthalmic Center, Sun Yat-sen University Guangzhou Guangdong China 510060

Sponsors and Collaborators

  • Sun Yat-sen University
  • First Affiliated Hospital, Sun Yat-Sen University

Investigators

  • Study Director: Weirong Chen, M.D., Zhongshan Ophthalmic Center, Sun Yat-sen University
  • Study Chair: Yizhi Liu, M.D.;Ph.D., Zhongshan Ophthalmic Center, Sun Yat-sen University
  • Principal Investigator: Haotian Lin, M.D.;Ph.D., Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Haotian Lin, Professor in Childhood Cataract Program of the Chinese Ministry of Health(CCPMOH), Zhongshan Ophthalmic Center, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT02644720
Other Study ID Numbers:
  • CCPMOH2010-China12
First Posted:
Jan 1, 2016
Last Update Posted:
Jan 1, 2016
Last Verified:
Dec 1, 2015
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 1, 2016